PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 133 filers reported holding PTC THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $468,846 | -93.2% | 12,600 | -91.2% | 0.00% | -94.3% |
Q4 2019 | $6,917,000 | +187.4% | 144,000 | +102.3% | 0.05% | +178.9% |
Q3 2019 | $2,407,000 | -33.1% | 71,167 | -11.0% | 0.02% | -26.9% |
Q2 2019 | $3,600,000 | +71.8% | 80,000 | +43.7% | 0.03% | +52.9% |
Q1 2019 | $2,095,000 | -10.7% | 55,657 | +11.5% | 0.02% | +13.3% |
Q3 2018 | $2,346,000 | +45.7% | 49,912 | -16.1% | 0.02% | +66.7% |
Q1 2018 | $1,610,000 | +83.8% | 59,523 | +13.4% | 0.01% | +125.0% |
Q4 2017 | $876,000 | +303.7% | 52,500 | +163.8% | 0.00% | +300.0% |
Q4 2016 | $217,000 | -84.5% | 19,900 | -80.1% | 0.00% | -85.7% |
Q3 2016 | $1,401,000 | +230.4% | 100,000 | +663.4% | 0.01% | +250.0% |
Q4 2015 | $424,000 | -91.1% | 13,100 | -92.7% | 0.00% | -92.6% |
Q3 2015 | $4,766,000 | -28.5% | 178,500 | +28.8% | 0.03% | -22.9% |
Q2 2015 | $6,668,000 | +39.3% | 138,541 | +76.2% | 0.04% | +29.6% |
Q1 2015 | $4,786,000 | +168.0% | 78,641 | +127.9% | 0.03% | +145.5% |
Q4 2014 | $1,786,000 | – | 34,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |